Therapeutic Strategies
Emerging Molecular and Genetic Approaches

The identification of genetic factors involved in sleep apnoea has opened the door for the development of novel targeted therapies.

Pharmacological Interventions

Preclinical studies have demonstrated the potential of pharmacological interventions that target the hypoxia-inducible factor (HIF) pathway to reduce sleep apnoea severity.

Gene Therapy Approaches

Additionally, gene therapy approaches, such as the delivery of neurotrophic factors to promote the survival and function of upper airway motor neurons, have shown promise in animal models of sleep apnoea.